Type |
Details |
Score |
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Prrg2/Prrg2 |
Background: |
C57BL/6N-Prrg2/Wtsi |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Prrg4/Prrg4 |
Background: |
C57BL/6NCrl-Prrg4/MbpMmucd |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
675
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
674
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
675
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
321
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
340
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
319
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Tashiro K |
Year: |
1993 |
Journal: |
Science |
Title: |
Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. |
Volume: |
261 |
Issue: |
5121 |
Pages: |
600-3 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sabbagh Y |
Year: |
2005 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. |
Volume: |
102 |
Issue: |
27 |
Pages: |
9637-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ducy P |
Year: |
1997 |
Journal: |
Cell |
Title: |
Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. |
Volume: |
89 |
Issue: |
5 |
Pages: |
747-54 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
460
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
481
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
492
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
481
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
481
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
493
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
234
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gla/? |
Background: |
involves: 129S4/SvJae * C57BL/6 |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gla/Gla Tg(CAG-A4GALT)#Sais/? |
Background: |
involves: 129S4/SvJae * C57BL/6 * C57BL/6JJms |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gla/? Tg(CAG-A4GALT)#Sais/? |
Background: |
involves: 129S4/SvJae * C57BL/6 * C57BL/6JJms |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
DO Term |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, targeted mutation, coisogenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, coisogenic, targeted mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Mgp/Mgp Spp1/Spp1 |
Background: |
involves: Black Swiss * C57BL/6J |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Eln/Eln<+> Mgp/Mgp |
Background: |
involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
446
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
446
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
471
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
470
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Nakamura M |
Year: |
2003 |
Journal: |
FASEB J |
Title: |
Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin. |
Volume: |
17 |
Issue: |
3 |
Pages: |
497-9 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
The GLA (gamma-carboxyglutamic acid-rich) domain contains glutamate residues that have been post-translationally modified by vitamin K-dependent carboxylation to form gamma-carboxyglutamate (Gla) [, , ]. All glutamic acid (Glu) residues present in the GLA domain are potential carboxylation sites; in coagulation proteins, all Gu residues are modified to Gla, while in osteocalcin and matrix Gla proteins only some Glu residues are modified to Gla. The GLA domain is responsible for the high-affinity binding of calcium ions. It starts at the N-terminal extremity of the mature form of proteins and ends with a conserved aromatic residue; a conserved Gla-x(3)-Gla-x-Cys motif []is found in the middle of the domain which seems to be important for substrate recognition by the carboxylase.The 3D structure of the GLA domain has been solved [, ]. Calcium ions induce conformational changes in the GLA domain that and are necessary for the proper folding of the GLA domain. A common structural feature of functional GLA domains is the clustering of N-terminal hydrophobic residues into a hydrophobic patch that mediates interaction with the cell surface membrane []. Proteins known to contain a GLA domain include []:Coagulation factor X []Coagulation factor VII []Coagulation factor IX []Coagulation factor XIV (vitamin K-dependent protein C) []Vitamin K-dependent protein S []Vitamin K-dependent protein Z []ProthrombinTransthyretinOsteocalcin (also known as bone-Gla protein, BGP)Matrix Gla protein (MGP) []Inter-alpha-trypsin inhibitor heavy chain H2Growth arrest-specific protein 6 (Gas-6) [] |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Homologous_superfamily |
Description: |
The GLA (gamma-carboxyglutamic acid-rich) domain contains glutamate residues that have been post-translationally modified by vitamin K-dependent carboxylation to form gamma-carboxyglutamate (Gla) [, , ]. All glutamic acid (Glu) residues present in the GLA domain are potential carboxylation sites; in coagulation proteins, all Gu residues are modified to Gla, while in osteocalcin and matrix Gla proteins only some Glu residues are modified to Gla. The GLA domain is responsible for the high-affinity binding of calcium ions. It starts at the N-terminal extremity of the mature form of proteins and ends with a conserved aromatic residue; a conserved Gla-x(3)-Gla-x-Cys motif []is found in the middle of the domain which seems to be important for substrate recognition by the carboxylase.The 3D structure of the GLA domain has been solved [, ]. Calcium ions induce conformational changes in the GLA domain that and are necessary for the proper folding of the GLA domain. A common structural feature of functional GLA domains is the clustering of N-terminal hydrophobic residues into a hydrophobic patch that mediates interaction with the cell surface membrane []. Proteins known to contain a GLA domain include []:Coagulation factor X []Coagulation factor VII []Coagulation factor IX []Coagulation factor XIV (vitamin K-dependent protein C) []Vitamin K-dependent protein S []Vitamin K-dependent protein Z []ProthrombinTransthyretinOsteocalcin (also known as bone-Gla protein, BGP)Matrix Gla protein (MGP) []Inter-alpha-trypsin inhibitor heavy chain H2Growth arrest-specific protein 6 (Gas-6) [] |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Mgp/Mgp Spp1/Spp1<+> |
Background: |
involves: Black Swiss * C57BL/6J |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Mgp/Mgp<+> Spp1/Spp1 |
Background: |
involves: Black Swiss * C57BL/6J |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Komori T |
Year: |
1997 |
Journal: |
Cell |
Title: |
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. |
Volume: |
89 |
Issue: |
5 |
Pages: |
755-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Castellino FJ |
Year: |
2008 |
Journal: |
Methods Mol Biol |
Title: |
gamma-Glutamate and beta-hydroxyaspartate in proteins. |
Volume: |
446 |
|
Pages: |
85-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fenaille F |
Year: |
2008 |
Journal: |
Glycoconj J |
Title: |
Mass spectrometric characterization of N- and O-glycans of plasma-derived coagulation factor VII. |
Volume: |
25 |
Issue: |
9 |
Pages: |
827-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Blostein M |
Year: |
2008 |
Journal: |
Haemophilia |
Title: |
The carboxylation efficiency of the vitamin K-dependent clotting factors: studies with factor IX. |
Volume: |
14 |
Issue: |
5 |
Pages: |
1063-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dai Q |
Year: |
2005 |
Journal: |
Biochemistry |
Title: |
Role of the hexapeptide disulfide loop in the gamma-carboxyglutamic acid domain of protein C in Ca2+-mediated structural and functional properties. |
Volume: |
44 |
Issue: |
37 |
Pages: |
12508-14 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saller F |
Year: |
2006 |
Journal: |
J Thromb Haemost |
Title: |
The protein S thrombin-sensitive region modulates phospholipid binding and the gamma-carboxyglutamic acid-rich (Gla) domain conformation in a non-specific manner. |
Volume: |
4 |
Issue: |
3 |
Pages: |
704-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sejima H |
Year: |
1990 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Primary structure of vitamin K-dependent human protein Z. |
Volume: |
171 |
Issue: |
2 |
Pages: |
661-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nakano T |
Year: |
1997 |
Journal: |
Biochem J |
Title: |
Requirement of gamma-carboxyglutamic acid residues for the biological activity of Gas6: contribution of endogenous Gas6 to the proliferation of vascular smooth muscle cells. |
Volume: |
323 ( Pt 2) |
|
Pages: |
387-92 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Mgp/Mgp<+> |
Background: |
involves: 129S4/SvJaeSor * C57BL/6NTac |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This family of proteins is found in bacteria and viruses. Proteins in this family are typically between 90 and 105 amino acids in length. There is a conserved GLA sequence motif. |
|
•
•
•
•
•
|
Allele |
Name: |
growth arrest specific 6; targeted mutation 1, Peter Carmeliet |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Publication |
First Author: |
Raefski AS |
Year: |
2007 |
Journal: |
J Mol Neurosci |
Title: |
Wnt pathway anomalies in developing amygdalae of Turner syndrome-like mice. |
Volume: |
32 |
Issue: |
2 |
Pages: |
111-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Khavandgar Z |
Year: |
2011 |
Journal: |
J Cell Biol |
Title: |
A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization. |
Volume: |
194 |
Issue: |
2 |
Pages: |
277-89 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gori F |
Year: |
2001 |
Journal: |
J Cell Biochem |
Title: |
Fibromodulin is expressed by both chondrocytes and osteoblasts during fetal bone development. |
Volume: |
82 |
Issue: |
1 |
Pages: |
46-57 |
|
•
•
•
•
•
|
Publication |
First Author: |
Angelillo-Scherrer A |
Year: |
2001 |
Journal: |
Nat Med |
Title: |
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. |
Volume: |
7 |
Issue: |
2 |
Pages: |
215-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Burnier L |
Year: |
2010 |
Journal: |
Blood |
Title: |
Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease. |
Volume: |
115 |
Issue: |
16 |
Pages: |
3390-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gruber RC |
Year: |
2014 |
Journal: |
J Neurosci |
Title: |
Targeted GAS6 delivery to the CNS protects axons from damage during experimental autoimmune encephalomyelitis. |
Volume: |
34 |
Issue: |
49 |
Pages: |
16320-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stenhoff J |
Year: |
2004 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts. |
Volume: |
319 |
Issue: |
3 |
Pages: |
871-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zahoor A |
Year: |
2020 |
Journal: |
J Cell Physiol |
Title: |
Gas6 negatively regulates the Staphylococcus aureus-induced inflammatory response via TLR signaling in the mouse mammary gland. |
Volume: |
235 |
Issue: |
10 |
Pages: |
7081-7093 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gely-Pernot A |
Year: |
2012 |
Journal: |
Stem Cells |
Title: |
An endogenous vitamin K-dependent mechanism regulates cell proliferation in the brain subventricular stem cell niche. |
Volume: |
30 |
Issue: |
4 |
Pages: |
719-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shibata T |
Year: |
2014 |
Journal: |
Am J Respir Cell Mol Biol |
Title: |
Role of growth arrest-specific gene 6 in the development of fungal allergic airway disease in mice. |
Volume: |
51 |
Issue: |
5 |
Pages: |
615-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mills KL |
Year: |
2018 |
Journal: |
PLoS One |
Title: |
Gas6 is dispensable for pubertal mammary gland development. |
Volume: |
13 |
Issue: |
12 |
Pages: |
e0208550 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nassar M |
Year: |
2017 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
GAS6 is a key homeostatic immunological regulator of host-commensal interactions in the oral mucosa. |
Volume: |
114 |
Issue: |
3 |
Pages: |
E337-E346 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maquoi E |
Year: |
2005 |
Journal: |
Arterioscler Thromb Vasc Biol |
Title: |
Role of Gas-6 in adipogenesis and nutritionally induced adipose tissue development in mice. |
Volume: |
25 |
Issue: |
5 |
Pages: |
1002-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Binder MD |
Year: |
2008 |
Journal: |
J Neurosci |
Title: |
Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination. |
Volume: |
28 |
Issue: |
20 |
Pages: |
5195-206 |
|
•
•
•
•
•
|
Publication |
First Author: |
Robins RS |
Year: |
2013 |
Journal: |
Blood |
Title: |
Vascular Gas6 contributes to thrombogenesis and promotes tissue factor up-regulation after vessel injury in mice. |
Volume: |
121 |
Issue: |
4 |
Pages: |
692-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tjwa M |
Year: |
2008 |
Journal: |
Blood |
Title: |
Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. |
Volume: |
111 |
Issue: |
8 |
Pages: |
4096-105 |
|
•
•
•
•
•
|
Publication |
First Author: |
Aghourian MN |
Year: |
2016 |
Journal: |
Blood |
Title: |
Prostaglandin E synthase is upregulated by Gas6 during cancer-induced venous thrombosis. |
Volume: |
127 |
Issue: |
6 |
Pages: |
769-77 |
|
•
•
•
•
•
|
Publication |
First Author: |
Binder MD |
Year: |
2011 |
Journal: |
PLoS One |
Title: |
Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination. |
Volume: |
6 |
Issue: |
3 |
Pages: |
e17727 |
|
•
•
•
•
•
|
Publication |
First Author: |
Laurance S |
Year: |
2017 |
Journal: |
Arterioscler Thromb Vasc Biol |
Title: |
Gas6 Promotes Inflammatory (CCR2hiCX3CR1lo) Monocyte Recruitment in Venous Thrombosis. |
Volume: |
37 |
Issue: |
7 |
Pages: |
1315-1322 |
|
•
•
•
•
•
|
Publication |
First Author: |
Park JK |
Year: |
2009 |
Journal: |
Hypertension |
Title: |
Growth arrest specific protein 6 participates in DOCA-induced target-organ damage. |
Volume: |
54 |
Issue: |
2 |
Pages: |
359-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bertin FR |
Year: |
2015 |
Journal: |
J Thromb Haemost |
Title: |
Growth arrest-specific 6 regulates thrombin-induced expression of vascular cell adhesion molecule-1 through forkhead box O1 in endothelial cells. |
Volume: |
13 |
Issue: |
12 |
Pages: |
2260-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Salian-Mehta S |
Year: |
2014 |
Journal: |
Mol Cell Endocrinol |
Title: |
Loss of Growth arrest specific gene 6 (Gas6) results in altered GnRH neuron migration, delayed vaginal opening and sexual maturation in mice. |
Volume: |
393 |
Issue: |
1-2 |
Pages: |
164-70 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gas6/Gas6 |
Background: |
involves: 129S1/Sv * 129X1/SvJ |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Jolliffe CN |
Year: |
2000 |
Journal: |
Biochem J |
Title: |
Identification of multiple proteins expressed in murine embryos as binding partners for the WW domains of the ubiquitin-protein ligase Nedd4. |
Volume: |
351 Pt 3 |
|
Pages: |
557-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Coutu DL |
Year: |
2008 |
Journal: |
J Biol Chem |
Title: |
Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. |
Volume: |
283 |
Issue: |
26 |
Pages: |
17991-8001 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sheen CR |
Year: |
2015 |
Journal: |
J Bone Miner Res |
Title: |
Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification. |
Volume: |
30 |
Issue: |
5 |
Pages: |
824-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Martinez ME |
Year: |
2022 |
Journal: |
JCI Insight |
Title: |
DIO3 protects against thyrotoxicosis-derived cranio-encephalic and cardiac congenital abnormalities. |
Volume: |
7 |
Issue: |
21 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Inada M |
Year: |
1999 |
Journal: |
Dev Dyn |
Title: |
Maturational disturbance of chondrocytes in Cbfa1-deficient mice. |
Volume: |
214 |
Issue: |
4 |
Pages: |
279-90 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, congenic, targeted mutation |
|
•
•
•
•
•
|
Publication |
First Author: |
Ray AK |
Year: |
2017 |
Journal: |
Glia |
Title: |
Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure. |
Volume: |
65 |
Issue: |
12 |
Pages: |
2051-2069 |
|
•
•
•
•
•
|
Publication |
First Author: |
Akkermann R |
Year: |
2017 |
Journal: |
Glia |
Title: |
The TAM receptor Tyro3 regulates myelination in the central nervous system. |
Volume: |
65 |
Issue: |
4 |
Pages: |
581-591 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fernlund P |
Year: |
1983 |
Journal: |
J Biol Chem |
Title: |
Beta-hydroxyaspartic acid in vitamin K-dependent proteins. |
Volume: |
258 |
Issue: |
20 |
Pages: |
12509-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
McMullen BA |
Year: |
1983 |
Journal: |
Biochem Biophys Res Commun |
Title: |
The occurrence of beta-hydroxyaspartic acid in the vitamin K-dependent blood coagulation zymogens. |
Volume: |
115 |
Issue: |
1 |
Pages: |
8-14 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stanley TB |
Year: |
1999 |
Journal: |
J Biol Chem |
Title: |
The propeptides of the vitamin K-dependent proteins possess different affinities for the vitamin K-dependent carboxylase. |
Volume: |
274 |
Issue: |
24 |
Pages: |
16940-4 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This group of plasma glycoproteins includes coagulation factors VII, IX, and X, and proteins C and Z, which belong to MEROPS peptidase family S1, subfamily S1A (chymotrypsin, clan PA(S)). All but protein Z are peptidases and are involved in blood coagulation. The precursors contain a signal sequence, propeptide, Gla domain, two EGF domains (although sometimes only one is detected by Pfam), and a trypsin domain. Except for protein Z, they are further cleaved between the second EGF domain and the trypsin domain into light and heavy chains, which are connected by a disulphide bond. Glutamic acid residues in the Gla domain undergo vitamin K-dependent carboxylation, allowing this region to bind calcium and membrane phospholipid []. The propeptide region is important in providing a recognition site for the gamma-carboxylase []. Typically one aspartic acid residue in the light chain is post-translationally modified to erythro-beta-hydroxyaspartic acid [, ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Prasad D |
Year: |
2006 |
Journal: |
Mol Cell Neurosci |
Title: |
TAM receptor function in the retinal pigment epithelium. |
Volume: |
33 |
Issue: |
1 |
Pages: |
96-108 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hong C |
Year: |
2012 |
Journal: |
J Clin Invest |
Title: |
Coordinate regulation of neutrophil homeostasis by liver X receptors in mice. |
Volume: |
122 |
Issue: |
1 |
Pages: |
337-47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lieben L |
Year: |
2013 |
Journal: |
Bone |
Title: |
Maternal hypervitaminosis D reduces fetal bone mass and mineral acquisition and leads to neonatal lethality. |
Volume: |
57 |
Issue: |
1 |
Pages: |
123-31 |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Publication |
First Author: |
Haack JA |
Year: |
1990 |
Journal: |
J Biol Chem |
Title: |
Conantokin-T. A gamma-carboxyglutamate containing peptide with N-methyl-d-aspartate antagonist activity. |
Volume: |
265 |
Issue: |
11 |
Pages: |
6025-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rigby AC |
Year: |
1997 |
Journal: |
Biochemistry |
Title: |
Role of gamma-carboxyglutamic acid in the calcium-induced structural transition of conantokin G, a conotoxin from the marine snail Conus geographus. |
Volume: |
36 |
Issue: |
50 |
Pages: |
15677-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Prorok M |
Year: |
2001 |
Journal: |
Curr Drug Targets |
Title: |
Structure-function relationships of the NMDA receptor antagonist conantokin peptides. |
Volume: |
2 |
Issue: |
3 |
Pages: |
313-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Blandl T |
Year: |
2001 |
Journal: |
J Biol Chem |
Title: |
Sequence requirements for the N-methyl-D-aspartate receptor antagonist activity of conantokin-R. |
Volume: |
276 |
Issue: |
10 |
Pages: |
7391-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jimenez EC |
Year: |
2002 |
Journal: |
Epilepsy Res |
Title: |
Conantokin-L, a new NMDA receptor antagonist: determinants for anticonvulsant potency. |
Volume: |
51 |
Issue: |
1-2 |
Pages: |
73-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Teichert RW |
Year: |
2007 |
Journal: |
J Biol Chem |
Title: |
Novel conantokins from Conus parius venom are specific antagonists of N-methyl-D-aspartate receptors. |
Volume: |
282 |
Issue: |
51 |
Pages: |
36905-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Twede VD |
Year: |
2009 |
Journal: |
Biochemistry |
Title: |
Conantokin-Br from Conus brettinghami and selectivity determinants for the NR2D subunit of the NMDA receptor. |
Volume: |
48 |
Issue: |
19 |
Pages: |
4063-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gowd KH |
Year: |
2008 |
Journal: |
Toxicon |
Title: |
Conantokin-P, an unusual conantokin with a long disulfide loop. |
Volume: |
52 |
Issue: |
2 |
Pages: |
203-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
White HS |
Year: |
2000 |
Journal: |
J Pharmacol Exp Ther |
Title: |
In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus. |
Volume: |
292 |
Issue: |
1 |
Pages: |
425-32 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Conserved_site |
Description: |
The conantokins are a family of neuroactive peptides found in the venoms of fish-hunting cone snails. They possess a relatively high number of residues (4-5) of the non-standard amino acid gamma-carboxyglutamic acid (Gla), which is generated by the post-translational modification of glutamate (Glu) residues. Conantokins are the only naturally produced peptides known to be N-methyl-D-aspartate (NMDA) receptor antagonists and show therapeutic promise in treating conditions associated with NMDA receptor dysfunction. In animal models they have exhibited anticonvulsant and anti-Parkinsonian properties and have provided neuroprotection within therapeutically acceptable times following transient focal brain ischemia [, , , ].Upon binding of Ca2+ to Gla, conantokin undergoes a conformational transition from a distorted curvilinear 3(10) helix to a linear α-helix. The binding of Ca2+ to conantokin leads to the exposure of a hydrophobic region on the opposite face of the helix []. Conantokins share relatively few sequence elements, which include include sequence identity at the first four residues, homologous positioning of the two most C-terminal Gla residues, and an Arg preceding the most C-terminal Gla [].The conantokin family is currently known to include:Conotoxin G from Conus geographus (Geography cone) (Nubecula geographus).Conantokin-L from Conus lynceus (Lynceus cone) [].Conantokin-R from Conus radiatus (Rayed cone) [].Conantokin-T from Conus tulipa (Fish-hunting cone snail) (Tulip cone) [].Conantokin-P from Conus purpurascens (Purple cone) [].Conantokin-Pr3 from Conus parius (Cone snail) [].Conantokin-Br Conus sulcatus (Sulcate cone) []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Drake TA |
Year: |
2001 |
Journal: |
J Orthop Res |
Title: |
Genetic loci influencing natural variations in femoral bone morphometry in mice. |
Volume: |
19 |
Issue: |
4 |
Pages: |
511-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Monroy M |
Year: |
2020 |
Journal: |
Development |
Title: |
Lymphatics in bone arise from pre-existing lymphatics. |
Volume: |
147 |
Issue: |
21 |
|
|
•
•
•
•
•
|